About MIMS
HEADQUARTERED IN SINGAPORE
Click on locations to find out more
Singapore
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
• Reference & Clinical Decision Support
Australia
Products and Services
• Reference & Clinical Decision Support
• e-Claiming & Billing Solutions
• HCPs Recruitment Services
China
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
• HCPs Recruitment Services
Hong Kong
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
India
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
• Reference & Clinical Decision Support
Indonesia
Ireland
Japan
Korea
Products and Services
• Marketing Platform
• Medical Communications
• Reference & Clinical Decision Support
• HCPs Recruitment Services
Malaysia
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
• HCPs Recruitment Services
Myanmar
New Zealand
Products and Services
• Reference & Clinical Decision Support
• e-Claiming & Billing Solutions
• HCPs Recruitment Services
Philippines
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
Taiwan
Thailand
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
UAE
Vietnam
Products and Services
• Drug Listing
• Marketing Platform
• Medical Communications
OUR ECOSYSTEM
OUR TEAM
Regional Management
Masaki Takahata
Chief Executive Officer
Masaki Takahata
Chief Executive Officer
Masaki Takahata is the Chief Executive Officer of MIMS Pte Ltd and leads a management team that works to deliver the company’s mission to empower healthcare communities to improve patient outcomes. Under his leadership, MIMS Group is building a progressive path to develop innovative digital solutions for healthcare publishing and knowledge sharing among industry professionals across Asia.
Masaki began his career at KPMG as an auditor responsible for multiple MNC clients in Japan. In the following years, as a management consultant, Masaki’s high order of professionalism, industry insight, local knowledge and hands-on approach accomplished multiple successful turnarounds for corporations in his portfolio.
In 2013, Masaki expanded his role and responsibilities at SMS Co. Ltd. He led several teams involved in corporate planning, investor relations, and mergers & acquisitions. He later successfully spearheaded the acquisition of MIMS and moved to Singapore to join the MIMS Group. He has been responsible for MIMS corporate functions which include corporate planning, finance, legal, HR, and IT, and became CEO in 2021.
Masaki is Certified Public Accountant in Japan and holds a Bachelor in economics from the University of Tokyo.
Tatsuya Koike
President, Recruiting Services
Tatsuya Koike
President, Recruiting Services
Tatsuya Koike is the President of Recruiting Services in MIMS. He leads regional teams in providing recruitment services and placement of healthcare professionals in clinics and hospitals in Asia Pacific.
Tatsuya began his career at MIMS’s parent company, Senior Marketing System (SMS) Co. Ltd. in Japan in 2007 as a Sales Representative of Media Division. He quickly progressed to become the Marketing Manager of Media Planning Division in 2008 and then the Product Manager of Care Vision. He became the Business Development Manager of Overseas Division in 2013 and was the Director of SMS Asia Pte. Ltd. in Singapore for 2 years before joining MIMS Group in 2017.
Tatsuya has more than five years of experience in Business Development and Management of Medical and IT sectors. He holds a Bachelor’s Degree in Chemistry at Saitama University, Japan.
Cassie Humphreys
President, Medical Marketing
Cassie Humphreys
President, Medical Marketing
Cassie will focus on driving the strategic growth of the Medical Communications and Marketing Platform business units as 𝐏𝐫𝐞𝐬𝐢𝐝𝐞𝐧𝐭, 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐔𝐧𝐢𝐭.
Following a degree in Medicinal and Pharmaceutical Chemistry, Cassie embarked on a marketing career in the pharmaceutical industry. With a reputation for commercial success, Cassie held positions ranging from Brand Manager to Marketing Director within top-tier pharmaceutical companies and ground-breaking biotech organisations.
Originally from the UK, in 2011 Cassie relocated to Singapore and with it came a move into medical communications, and ultimately, MIMS Group.
Under Cassie’s leadership, the team have built a reputation for excellence – forging strategic partnerships with clients in healthcare to deliver world class services across Asia and beyond.
Sohil Goswami
President,
Clinical Decision Solutions; President, Listing; Director, CEO Office
Sohil Goswami
President, Clinical Decision Solutions; President, Listing;
Director, CEO Office
Sohil, President of the CDS Strategic Unit and Listing Business Unit at MIMS Group, drives strategic growth for Clinical Decision Solutions and Listing businesses in APAC, Middle East, and Oceania, overseeing sales and operations. He also serves as Director of the CEO Office, leading a team in designing and executing company-wide strategic initiatives with the MIMS Group CEO.
He brings over 15 years of experience in product development and value chain transformation from his roles at NEC Corporation in Japan, Deloitte Consulting in Japan, and Nomura Group in Singapore. Sohil is a specialist in digital transformation, value chain restructuring, and corporate strategy, working hands-on in offices across Japan, India, and Asia with diverse teams.
Since joining MIMS Group in 2019, Sohil has worked closely with the SMS Co. and the MIMS Board to achieve post M&A transformation on MIMS group, impacting key businesses and markets by leading efforts revamping products and business models, implementing digital initiatives, and restructuring sales and delivery operations.
Sohil holds an MBA from the National University of Singapore in strategy and organization and is fluent in business Japanese (N1), and is a certified Project Management Professional (PMI-PMP).
Yasuyuki Hayashi
Executive Vice President, MPF User Engagement Development
Yasuyuki Hayashi
Executive Vice President, MPF User Engagement Development
Yasuyuki Hayashi (Yaz) is the Executive Vice President, MPF User Engagement Development, leading the planning, development and operations of medical information and education service at MIMS.
Yaz started his career as a software engineer and R&D researcher at Rakuten, a major e-commerce company in Japan. He also spent time as a project manager at a digital marketing development firm, Information Services International-Dentsu.
In the last six years, he moved over to the business side – handling global partner alliances, post-merger integrations, business turnarounds and accelerations for
an online beauty media and fashion e-commerce business in Japan.
Yaz is now based in Singapore after joining MIMS in 2022.
He has a PhD in Applied Physics in The University of Tokyo and a Bachelor in Physics from Osaka University.
Robert Best
Executive Vice President, Clinical Decision Solutions Pacific
Robert Best
Executive Vice President, Clinical Decision Solutions Pacific
Leading the Australasian region, Robert has several roles – CEO & Executive Director for MIMS Australia and MIMS New Zealand (ANZ), CEO and Executive Director of eHealthWise Services and currently a Board Member of the MSIA (Medical Software Industry Association) in Australia.
His corporate responsibility is to drive the strategy, P&L, growth and operations across these 3 Asia-Pacific businesses, working closely with our Group CEO and Executive Team (Singapore HQ).
Robert led the acquisition of eHealthwise Services in January 2014 to SMS Co Limited, and assisted our Tokyo HQ team with the October 2015 MIMS Group acquisition.
Robert continues to focus on M&A opportunities across the region and has worked with our Shareholder owners, SMS Co, since 2013.
Robert is University Degree qualified – Bachelor of Commerce (Majors in; International Business, Technology delivery, Strategy/Marketing/Advertising/Brand Building) – he provides MIMS with 25 years of diverse skills; with significant APAC experience, Board Leadership, Corporate Governance and IP Commercialization across Public and Private Companies.
Yang Xuan
Managing Director, Medical Marketing, China
Yang Xuan
Managing Director, Medical Marketing, China
Yang Xuan has over 20 years of working experience in healthcare communications.
CME and KOL management were the major responsibilities for her first 5 years working under McCann healthcare in Tokyo, Shanghai, New Jersey and Beijing.
She became the Managing Director one year after she joined Euro RSCG Life China (Havas Life). Her responsibilities were not only business development, but she was also responsible for business operations. Her 8 years of extensive working records had left Euro RSCG Life a best business winning records in both Rx and OTC brands, rich long-term serving client list, many domestic and international creative awards, and efficient campaign awards winner as a perfect ending.
MIMS had motivated Yang Xuan to return to major healthcare communication agency from her own firm, she has built a strong and trusted team here, long-term dedication, in-depth understanding to this market, most up-to-date communication concept and multi-channel tool design, smart phone based platform delivery in particularly has enabled MIMS to become the leading agency among chaos.
OUR HISTORY
2017
Expansion to Taiwan, China
The latest expansion meets growing demand in Taiwan for medical communications services in the healthcare industry.
The new Taiwan branch has a professional team of members from both Taiwan and Hong Kong delivering medical communications solutions catering to the Taiwan market, with a regional perspective and through a multidisciplinary and integrated approach.
2015
Launch of HCPs Recruitment Services
With the HCPs Recruitment Services, we provide career opportunities to HCPs by connecting them with healthcare institutions. Our career services professionals can tailor match the institutions’ needs to a diverse group of professionals engaged on our platform.
2013
Launch of MIMS Mobile App
To allow convenient access, MIMS developed the mobile application version of MIMS.com and released the application available for download by public on Google Playstore and Apple Store.
2008
Launch of MIMS.com
MIMS.com was enhanced and relaunched to allow registrations of HCPs onto our platform for easy access to drug information, medical news and updates.
2003-2008
Development and Launch of Clinical Decision Support Modules
Modules leveraged on the robust MIMS database and sophisticated drug interaction algorithms to enable MIMS to empower HCPs and Healthcare Institutions with accurate prescriptions, enhancing patient safety.
1981
Launch of Publications: MIMS JPOG and MIMS Doctor
1963-1980
Launch of MIMS Drug Reference Book
The 1st edition of Drug Index for Malaysia & Singapore (DIMS) was published in 1968.
MIMS Australia has been publishing medicines information since 1963. The acronym, MIMS, was derived from the original publication which was called Monthly Index of Medical Specialties.
The MIMS Drug Reference Book was subsequently published across Southeast Asia – Philippines, Hong Kong, Indonesia, Thailand, Korea, Taiwan, Vietnam, China and India.